| No. 22-37 | |
| Title: | Teva Pharmaceuticals USA, Inc., Petitioner v. GlaxoSmithKline LLC, et al. |
| Docketed: | July 13, 2022 |
| Linked with 21A677 | |
| Lower Ct: | United States Court of Appeals for the Federal Circuit |
| Case Numbers: | (2018-1976, 2018-2023) |
| Decision Date: | August 5, 2021 |
| Rehearing Denied: | February 11, 2022 |
| Date | Proceedings and Orders |
| Apr 29 2022 | Application (21A677) to extend the time to file a petition for a writ of certiorari from May 12, 2022 to July 11, 2022, submitted to The Chief Justice. |
| Main DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsLower Court Orders/Opinions | |
| May 03 2022 | Application (21A677) granted by The Chief Justice extending the time to file until July 11, 2022. |
| Jul 11 2022 | Petition for a writ of certiorari filed. (Response due August 12, 2022) |
| PetitionAppendixCertificate of Word CountProof of Service | |
| Jul 25 2022 | Motion to extend the time to file a response from August 12, 2022 to September 12, 2022, submitted to The Clerk. |
| Main Document | |
| Jul 26 2022 | Motion to extend the time to file a response is granted and the time is extended to and including September 12, 2022. |
| Aug 10 2022 | Brief amici curiae of 42 Professors of Law, Economics, Business, and Medicine filed. |
| Main DocumentProof of ServiceCertificate of Word Count | |
| Aug 12 2022 | Brief amicus curiae of Alvotech filed. |
| Main DocumentProof of ServiceCertificate of Word Count | |
| Aug 12 2022 | Brief amicus curiae of Mylan Pharmaceuticals Inc. filed. |
| Main DocumentProof of ServiceCertificate of Word Count | |
| Aug 12 2022 | Brief amicus curiae of Association for Accessible Medicines filed. |
| Main DocumentProof of ServiceCertificate of Word Count | |
| Aug 19 2022 | Brief of respondents GlaxoSmithKline LLC, et al. in opposition filed. |
| Main DocumentProof of ServiceCertificate of Word Count | |
| Sep 07 2022 | DISTRIBUTED for Conference of 9/28/2022. |
| Sep 07 2022 | Reply of petitioner Teva Pharmaceuticals USA, Inc. filed. (Distributed) |
| Main DocumentProof of ServiceCertificate of Word Count | |
| Oct 03 2022 | The Solicitor General is invited to file a brief in this case expressing the views of the United States. |
| NAME | ADDRESS | PHONE |
| Attorneys for Petitioner | ||
| William McGinley Jay Counsel of Record | Goodwin Procter, LLP 1900 N Street, N.W. Washington, DC 20036 WJay@goodwinlaw.com | 2023464190 |
| Party name: Teva Pharmaceuticals USA, Inc. | ||
| Attorneys for Respondents | ||
| Juanita R. Brooks Counsel of Record | Fish & Richardson 12860 El Camino Real Suite 400 San Diego, CA 92130 brooks@fr.com | 858-678-4377 |
| Party name: GlaxoSmithKline LLC, et al. | ||
| Other | ||
| Charles Duan Counsel of Record | 2701 Calvert St NW Apt 623 Washington, DC 20008 supremecourt.gov@cduan.com | (202) 525-5717 |
| Party name: 42 Professors of Law, Economics, Business, and Medicine | ||
| Jonathan Yates Ellis Counsel of Record | McGuireWoods LLP 888 16th Street N.W. Suite 500 Washington, DC 20006 jellis@mcguirewoods.com | 202-828-2887 |
| Party name: Alvotech | ||
| Matthew S. Hellman Counsel of Record | Jenner & Block LLP 1099 New York Ave., NW Suite 900 Washington, DC 20001 mhellman@jenner.com | 202-639-6000 |
| Party name: Association for Accessible Medicines | ||
| Steffen Nathanael Johnson Counsel of Record | Wilson Sonsini Goodrich & Rosati 1700 K Street, NW, Fifth Floor Washington, DC 20006 sjohnson@wsgr.com | (202) 973-8888 |
| Party name: Mylan Pharmaceuticals Inc. | ||